BRAF and colorectal cancer: Moreover, MSS tumours with BRAF mutations usually have high methylation levels, suggesting that the poor survival of patients with colorectal cancer with BRAF mutations is attributed to the relationship between high methylation levels and poor prognosis (Pinson et al., 2020).